Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC155

Blínatúmómab

  • Status:
    Veitt
  • Application date:
    18.5.2016
  • Application published:
    15.6.2016
  • Grant published:
    15.6.2017
  • Max expiry date:
    25.11.2029
  • Next due date:
    30.11.2026
  • Medicine name:
    Blincyto
  • Medicine for children:
    No

Timeline

Today
18.5.2016Application
15.6.2016Publication
15.6.2017Registration
25.11.2026Expires

Marketing license

  • IS authorization number:
    EU/1/15/1047/001
  • Date:
    16.12.2015
  • Foreign authorization number:
    EU/1/15/1047
  • Date:
    23.11.2015

Owner

  • Name:
    Amgen Research (Münich) GmbH
  • Address:
    Staffelseestrasse 2, München DE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 25.10.2024

Expires: 25.11.2025

Payer: Árnason Faktor ehf.

Number: 2

Paid: 17.11.2025

Expires: 25.11.2026

Payer: Árnason Faktor ehf.

Upload documents